naringenin has been researched along with Obesity in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 9 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, BY; Jo, YH; Kim, SB; Lee, JW; Lee, MK; Liu, Q | 1 |
| Javad Hosseinzadeh-Attar, M; Mahdi Rezayat, S; Mansouri, S; Naeini, F; Namkhah, Z | 1 |
| Yoshida, H | 1 |
| Hosseinzadeh-Attar, MJ; Jazayeri-Tehrani, SA; Mansouri, S; Naeini, F; Namkhah, Z; Rezayat, SM; Tutunchi, H; Yaseri, M | 1 |
| Hosseinzadeh-Attar, MJ; Mansouri, S; Naeini, F; Namkhah, Z; Rezayat, SM; Tutunchi, H; Yaseri, M | 1 |
| Che, J; Liu, H; Yao, W; Zhao, H | 1 |
| Li, J; Shi, X; Si, Q; Tan, X; Zhang, S | 1 |
| Domínguez-Avila, JA; González-Aguilar, GA; López-Almada, G; Mejía-León, ME; Robles-Sánchez, M; Salazar-López, NJ | 1 |
| Coulter, AA; Coulter, CR; Cusimano, LA; Ghosh, S; Greenway, FL; He, Y; James, SL; Rebello, CJ; Zhang, D | 1 |
| Banh, T; Belury, MA; Cole, RM; Hsiao, YH; Ke, JY; Straka, SR; Yee, LD | 1 |
| Coulter, AA; Greenway, FL; Johnson, WD; Lau, FH; Lin, Y; Rebello, CJ; Stephens, JM | 1 |
| Cao, W; Chen, S; Cheng, N; Liu, X; Zhao, H | 1 |
| Kurokawa, M; Sugita, C; Tsuhako, R; Yoshida, H | 1 |
| Alam, MA; Rahman, MM; Reza, HM; Sarker, SD; Subhan, N; Uddin, SJ | 1 |
| Atsumi, T; Ishida, A; Kurokawa, M; Narumi, K; Sugita, C; Watanabe, H; Watanabe, W; Yoshida, H | 1 |
| Adams, AC; Assini, JM; Burke, AC; Chhoker, SS; Drangova, M; Huff, MW; Kharitonenkov, A; Mulvihill, EE; Pin, CL; Sawyez, CG; Sutherland, BG; Telford, DE | 1 |
| Belury, MA; Cole, RM; Cotten, BM; Hamad, EM; Hsiao, YH; Ke, JY; Powell, KA | 1 |
| Assini, JM; DiMattia, AS; Huff, MW; Khami, M; Koppes, JB; Mulvihill, EE; Sawyez, CG; Sutherland, BG; Whitman, SC | 1 |
3 review(s) available for naringenin and Obesity
| Article | Year |
|---|---|
[Preventive and Ameliorating Effects of Food Factors on Obesity-related Diseases by Regulating Inflammation].
Topics: Adipocytes; Adipose Tissue; Aged; Animals; Citrus; Diabetes Mellitus; Female; Flavanones; Flavonoids; Food-Drug Interactions; Humans; Hypoglycemic Agents; Inflammation; Japan; Life Style; Male; Mice; Middle Aged; Obesity; Social Problems | 2021 |
Could Naringenin Participate as a Regulator of Obesity and Satiety?
Topics: Diabetes Mellitus, Type 2; Flavanones; Humans; Inflammation; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity | 2023 |
Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
Topics: Anti-Inflammatory Agents; Antioxidants; Citrus; Flavanones; Humans; Inflammation; Lipid Metabolism; Metabolic Syndrome; Obesity; Oxidative Stress; Phytotherapy; Plant Extracts | 2014 |
3 trial(s) available for naringenin and Obesity
| Article | Year |
|---|---|
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
Topics: Dietary Supplements; Double-Blind Method; Flavanones; Humans; Iran; Lipids; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Probability | 2021 |
Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Topics: Dietary Supplements; Double-Blind Method; Flavanones; Humans; Iran; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Randomized Controlled Trials as Topic | 2021 |
Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.
Topics: Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Flavanones; Heart Disease Risk Factors; Humans; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Risk Factors | 2022 |
12 other study(ies) available for naringenin and Obesity
| Article | Year |
|---|---|
Benzylated and prenylated flavonoids from the root barks of Cudrania tricuspidata with pancreatic lipase inhibitory activity.
Topics: Biological Products; Flavonoids; Lipase; Molecular Structure; Moraceae; Obesity; Pancreas; Plant Extracts | 2015 |
Naringenin Protects against Hypertension by Regulating Lipid Disorder and Oxidative Stress in a Rat Model.
Topics: Adipokines; Animals; Cholesterol; Flavanones; Hypertension; Lipoproteins, HDL; Obesity; Oxidative Stress; Rats; Superoxide Dismutase; Triglycerides | 2022 |
Naringenin activates beige adipocyte browning in high fat diet-fed C57BL/6 mice by shaping the gut microbiota.
Topics: Adipocytes, Beige; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Bacterial Agents; Diet, High-Fat; Energy Metabolism; Flavanones; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Obesity | 2022 |
Naringenin and β-carotene convert human white adipocytes to a beige phenotype and elevate hormone- stimulated lipolysis.
Topics: Adipocytes, White; beta Carotene; Glucose; Hormones; Humans; Insulin Resistance; Lipolysis; Obesity; Phenotype; PPAR gamma; Triglycerides | 2023 |
Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.
Topics: Adipose Tissue; Adiposity; AMP-Activated Protein Kinases; Animals; Body Weight; Cell Line, Tumor; Cell Survival; Female; Flavanones; Inflammation; Insulin; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Obesity; Ovariectomy | 2017 |
Naringenin Promotes Thermogenic Gene Expression in Human White Adipose Tissue.
Topics: Adipose Tissue, White; Animals; Flavanones; Gene Expression; Humans; Male; Mice; Obesity; Thermogenesis | 2019 |
Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice.
Topics: Animals; Bees; Diet, High-Fat; Disease Models, Animal; Flavanones; Flavonoids; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Pollen; Rutin; Schisandra | 2019 |
Naringenin suppresses neutrophil infiltration into adipose tissue in high-fat diet-induced obese mice.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Cell Line; Chemokine CCL2; Chemokine CCL7; Chemokine CXCL2; Coculture Techniques; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavanones; Inflammation; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neutrophil Infiltration; Obesity; RAW 264.7 Cells | 2020 |
Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Anthracenes; Cell Line; Chemokine CCL2; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavanones; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Obesity; RNA, Messenger; Time Factors | 2014 |
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Topics: Adipose Tissue; Animals; Fatty Liver; Fibroblast Growth Factors; Flavanones; Glucose Intolerance; Male; Mice; Mice, Knockout; Obesity | 2015 |
Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice.
Topics: Animals; Body Weight; Citrus; Dietary Supplements; Diglycerides; Energy Intake; Energy Metabolism; Female; Flavanones; Mice, Inbred C57BL; Motor Activity; Muscle, Skeletal; Obesity; Ovariectomy; Postmenopause; Tissue Distribution | 2016 |
Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cholesterol; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Fatty Liver; Flavanones; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptors, LDL; Time Factors; Triglycerides | 2010 |